CYP4F2 and coronary artery disorder: Various studies have revealed that single nucleotide polymorphisms (SNPs) in CYP4A11 and CYP4F2 have an impact on expression or catalytic activity of these enzymes, thereby contributing to the molecular basis of cardiovascular disorders including CAD [17, 19–24].